Literature DB >> 26575940

C-Terminal Domain of Integrase Binds between the Two Active Sites.

Victoria A Roberts1.   

Abstract

HIV integrase (HIV-IN), one of three HIV enzymes, is a target for the treatment of AIDS, but the full biological assembly has been difficult to characterize, hampering inhibitor design. The recent crystallographic structures of integrase from prototype foamy virus (PFV-IN) with bound DNA were a breakthrough, revealing how viral DNA organizes two integrase dimers into a tetramer that has the two active sites appropriately spaced for insertion of the viral DNA into host DNA. The organization of domains within each PFV-IN protein chain, however, varies significantly from that found in HIV-IN structures. With the goal of identifying shared structural characteristics, the interactions among components of the PFV-IN and HIV-IN assemblies were investigated with the macromolecular docking program DOT. DOT performs an exhaustive, rigid-body search between two macromolecules. Computational docking reproduced the crystallographic interactions of the PFV-IN catalytic and N-terminal domains with viral DNA and found similar viral DNA interactions for HIV-IN. Computational docking did not reproduce the crystallographic interactions of the PFV-IN C-terminal domain (CTD). Instead, two symmetry-related positions were found for the PFV-IN CTD that indicate formation of a CTD dimer between the two active sites. Our predicted CTD dimer is consistent with cross-linking studies showing interactions of the CTD with viral DNA that appear to be blocked in the PFV-IN structures. The CTD dimer can insert two arginine-rich loops between the two bound vDNA molecules and the host DNA, a region that is unoccupied in the PFV-IN crystallographic structures. The positive potential from these two loops would alleviate the large negative potential created by the close proximity of two viral vDNA ends, helping to bring together the two active sites and assisting host DNA binding. This study demonstrates the ability of computational docking to evaluate complex crystallographic assemblies, identify interactions that are influenced by the crystal environment, and provide plausible alternatives.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26575940      PMCID: PMC4689733          DOI: 10.1021/ct501125r

Source DB:  PubMed          Journal:  J Chem Theory Comput        ISSN: 1549-9618            Impact factor:   6.006


  63 in total

1.  Complex of linker histone H5 with the nucleosome and its implications for chromatin packing.

Authors:  Li Fan; Victoria A Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

2.  XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations.

Authors:  Li Fan; Jill O Fuss; Quen J Cheng; Andrew S Arvai; Michal Hammel; Victoria A Roberts; Priscilla K Cooper; John A Tainer
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

3.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

4.  HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.

Authors:  Peter Cherepanov; Goedele Maertens; Paul Proost; Bart Devreese; Jozef Van Beeumen; Yves Engelborghs; Erik De Clercq; Zeger Debyser
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

5.  Structure-based modeling of the functional HIV-1 intasome and its inhibition.

Authors:  Lavanya Krishnan; Xiang Li; Hema L Naraharisetty; Stephen Hare; Peter Cherepanov; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy.

Authors:  Svetlana Kotova; Min Li; Emilios K Dimitriadis; Robert Craigie
Journal:  J Mol Biol       Date:  2010-04-21       Impact factor: 5.469

7.  Retroviral intasome assembly and inhibition of DNA strand transfer.

Authors:  Stephen Hare; Saumya Shree Gupta; Eugene Valkov; Alan Engelman; Peter Cherepanov
Journal:  Nature       Date:  2010-01-31       Impact factor: 49.962

Review 8.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

9.  Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor.

Authors:  Fabrice Michel; Corinne Crucifix; Florence Granger; Sylvia Eiler; Jean-François Mouscadet; Sergei Korolev; Julia Agapkina; Rustam Ziganshin; Marina Gottikh; Alexis Nazabal; Stéphane Emiliani; Richard Benarous; Dino Moras; Patrick Schultz; Marc Ruff
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

10.  A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75.

Authors:  Stephen Hare; Ming-Chieh Shun; Saumya Shree Gupta; Eugene Valkov; Alan Engelman; Peter Cherepanov
Journal:  PLoS Pathog       Date:  2009-01-09       Impact factor: 6.823

View more
  2 in total

1.  The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical.

Authors:  Meytal Galilee; Elena Britan-Rosich; Sarah L Griner; Serdar Uysal; Viola Baumgärtel; Don C Lamb; Anthony A Kossiakoff; Moshe Kotler; Robert M Stroud; Ailie Marx; Akram Alian
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

2.  Considering both small and large scale motions of vascular endothelial growth factor (VEGF) is crucial for reliably predicting its binding affinities to DNA aptamers.

Authors:  Wook Lee; Jae Whee Park; Yeon Ju Go; Won Jong Kim; Young Min Rhee
Journal:  RSC Adv       Date:  2021-03-01       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.